Literature DB >> 12089672

Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.

Bernard Beall1, M Catherine McEllistrem, Robert E Gertz, David J Boxrud, John M Besser, Lee H Harrison, James H Jorgensen, Cynthia G Whitney.   

Abstract

Monitoring antibiotic-resistant pneumococcal strains not covered by the 7-valent conjugate vaccine is an important priority. The Centers for Disease Control and Prevention's Active Bacterial Core Surveillance identified 68 invasive penicillin-nonsusceptible serotype 35B (PN35B) isolates recovered from 1995 to 2001 from patients residing in the states of California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New York, Oregon, Tennessee, and Texas. Nonsusceptible isolates accounted for 69% of all serotype 35B isolates recovered during this time. Twelve (18%) of the 68 PN35B isolates recovered since 1995 were obtained from pediatric patients. These 68 isolates exhibited penicillin MICs of 0.25-2 microg/mL and reduced susceptibility to cefotaxime. Representative PN35B isolates exhibited a common chromosomal macrorestriction profile and identical penicillin-binding-protein gene restriction profiles characteristic of penicillin-resistant strains, and they shared a unique 7-locus sequence type that included 3 new alleles. The mosaic pbp2b and divergent ddl sequences were suggestive of interspecies recombination at the ddl-pbp2b chromosomal region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089672     DOI: 10.1086/341072

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Authors:  Ronald J Stanek; Mary B Maher; Nancy B Norton; Maurice A Mufson
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.

Authors:  Mathias W R Pletz; Lesley McGee; Bernard Beall; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.

Authors:  Kei Kasahara; Koichi Maeda; Keiichi Mikasa; Kenji Uno; Ken Takahashi; Mitsuru Konishi; Eiichiro Yoshimoto; Koichi Murakawa; Eiji Kita; Hiroshi Kimura
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  The Ongoing Genetic Adaptation of Streptococcus pneumoniae.

Authors:  Sandra S Richter; Daniel M Musher
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

5.  Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.

Authors:  Rodrigo E Mendes; Donald Biek; Ian A Critchley; David J Farrell; Helio S Sader; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

6.  Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.

Authors:  Liset Olarte; Sheldon L Kaplan; William J Barson; José R Romero; Philana Ling Lin; Tina Q Tan; Jill A Hoffman; John S Bradley; Laurence B Givner; Edward O Mason; Kristina G Hultén
Journal:  J Clin Microbiol       Date:  2016-11-09       Impact factor: 5.948

7.  Genomic Epidemiology of Penicillin-Nonsusceptible Pneumococci with Nonvaccine Serotypes Causing Invasive Disease in the United States.

Authors:  Cheryl P Andam; Patrick K Mitchell; Alanna Callendrello; Qiuzhi Chang; Jukka Corander; Chrispin Chaguza; Lesley McGee; Bernard W Beall; William P Hanage
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

8.  Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Authors:  Sandra S Richter; Daniel J Diekema; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

9.  Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine.

Authors:  Mathias W R Pletz; Lesley McGee; James Jorgensen; Bernard Beall; Richard R Facklam; Cynthia G Whitney; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel.

Authors:  David Greenberg; Ron Dagan; Marie Muallem; Nurith Porat
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.